The International Prostate Symptom Score (IPSS) is an eight-question screening tool developed to assess the severity of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). It includes seven questions about urinary symptoms (e.g., frequency, urgency, weak stream) and one question on quality of life.
The total score ranges from 0 to 35, with severity classified as mild (0-7), moderate (8-19) and severe (20-35)
The international Prostate Symptom Score (IPSS) is divided into two subscores:
These subscores categorize the seven symptom-related questions into two groups based on the nature of the symptoms.